Blood Analyzers

Bruker Corporation is a global leader in high-performance scientific instruments and analytical solutions for life sciences research and diagnostics. The company manufactures a broad portfolio of analytical instruments including nuclear magnetic resonance (NMR) spectrometers, X-ray fluorescence (XRF) spectrometers, Fourier-transform infrared (FT-IR) and Raman spectrometers, electron paramagnetic resonance (EPR) systems, and advanced microscopy platforms. Bruker's diagnostic division offers the MALDI Biotyper® and IR Biotyper® systems for microbial identification, as well as the MyGenius PRO® molecular diagnostics system for sample-to-answer PCR-based infectious disease testing. The company also provides spatial biology platforms for multi-omics analysis (DNA, RNA, protein) and light-sheet microscopy systems such as the Papilio5D for 3D cell culture imaging. Bruker serves academia, biopharma, clinical diagnostics, and industrial markets globally. Products include handheld XRF analyzers (TITAN), bench-top vacuum FT-IR spectrometers (VERTEX NEO Ultra), nanomechanical testing systems (Hysitron PI Envision), and specialty analyzers for dairy and food quality control (MOVE-T). The company maintains significant R&D capabilities and offers comprehensive customer support services, consumables, accessories, and software through the Bruker Store. Bruker operates manufacturing and R&D facilities in Billerica, Massachusetts, and globally.

Scantibodies Laboratory, Inc. is a privately held biotech manufacturer established in 1976, specializing in the production and purification of monoclonal and polyclonal antibodies, heterophilic blocking reagents (HBR), controls, calibrators, and human/animal serum and plasma. The company operates over 1 million square feet of owned manufacturing and temperature-controlled warehouse facilities across multiple locations, including Santee, California and Tecate, Mexico, with expansion plans for a 1.5 million square foot campus in Tijuana. Core competencies include contract manufacturing, lyophilization (with 2,756 sq. ft. of shelf capacity), automated filling and capping at 125 vials per minute with weight verification, packaging, and third-party logistics with temperature-controlled transportation via owned trucking fleet. Notable achievements include manufacturing 1.25 million COVID-19 tests per day and over 200 million over-the-counter pregnancy tests. The company serves clinical laboratory, diagnostic, and IVD (in vitro diagnostic) markets. ISO 13485 certified. Approximately 500 employees. The company also operates a patient care division offering medical imaging and personalized therapeutic services.

Diazyme Laboratories, Inc. is a San Diego-based manufacturer of diagnostic reagents and automated clinical chemistry analyzers. The company specializes in enzyme immunoassay and immunoturbidimetric technologies for automated laboratory analyzers. Product portfolio includes assays for cardiovascular markers (Lp-PLA2 via PLAC® Test, FDA-cleared), cancer markers (kappa and lambda free light chains), sepsis markers (procalcitonin), renal function (cystatin C, creatinine), liver function (total bile acids), diabetic markers (glycated serum protein), gastrointestinal health (calprotectin, lactoferrin), neurodegenerative biomarkers (phosphorylated tau variants, amyloid-beta, neurofilament light chain—mostly in development), and specialty assays (pancreatic elastase, serum amyloid A, vitamin D). The company manufactures the DZ-Lite c270 clinical chemistry analyzer, a fully automated system capable of 270 tests/hour supporting 1–4 reagent assays. Diazyme holds FDA 510(k) clearances for multiple assays and CLIA certification for US distribution. The company serves clinical laboratories, hospitals, and diagnostics networks with liquid-stable, ready-to-use reagent systems compatible with major automated analyzers. Manufacturing and distribution capabilities support both domestic (US) and international markets.

CHRONO-LOG CORP. designs, develops, and manufactures innovative platelet function testing systems for clinical and research laboratories. The company specializes in platelet aggregation and secretion methodologies used to diagnose platelet function defects, monitor anti-platelet drug therapy, and identify bleeding or thrombotic risk in patients. CHRONO-LOG offers three primary testing platforms: Whole Blood/Impedance Aggregation for rapid platelet function screening in physiologic whole blood environments with reduced sample preparation; Optical/Light Transmission Aggregation (LTA) using dual-beam detection for improved sensitivity with micro-volume samples (250 µL); and ATP Release analysis for quantitative measurement of dense granule secretion and simultaneous aggregation-secretion studies. The company also provides Ristocetin CoFactor Assay systems for Von Willebrand Disease diagnosis, with capabilities to detect Type 3 disease at 3% activity levels. CHRONO-LOG systems are used to diagnose specific platelet disorders including Von Willebrand Disease, Glanzmann's Thrombasthenia, Storage Pool Disease, and secretion defects. The platform supports PRP, washed, and gel-filtered platelet testing. CHRONO-LOG's aggregation systems and reagents are FDA-cleared and CE-marked. The company serves hematology, hemostasis, and thrombosis laboratories globally, supporting patient risk stratification, anti-platelet drug selection and monitoring, and research into novel hemostatic therapies. CHRONO-LOG emphasizes reduced blood draw volumes, faster turnaround times, and lower labor intensity compared to alternative platelet function testing methods.

Sysmex Corporation is a global clinical laboratory diagnostics manufacturer specializing in hematology, hemostasis, urinalysis, flow cytometry, and laboratory informatics solutions. The company designs and manufactures fully automated and compact hematology analyzers, hemostasis testing systems, and urinalysis instruments for clinical laboratory environments ranging from high-volume reference labs to low-volume hospital labs. Sysmex's product portfolio includes the CN-6000 hemostasis analyzer for specialty testing and the UN-Series urinalysis systems. The company provides automated complete blood count (CBC) analyzers that perform approximately 400 million tests annually across 12,000+ clinical laboratories worldwide. Sysmex offers trusted reagents for routine and specialty testing, integrated laboratory information systems, and comprehensive service and support programs. The company has achieved 90% auto-validation rates in CBC testing and ranked #1 in hematology analyzer reliability, system performance, and service support for over 20 years according to independent IMV ServiceTrak surveys. Sysmex holds 2024 IMV ServiceTrak Awards for Best Customer Satisfaction, Best System Performance, and Best Service in hematology. The company serves hospital labs, reference laboratories, and clinical diagnostic centers with regulatory compliance and quality assurance across all product lines.

EUROIMMUN US, a subsidiary of the global leader EUROIMMUN Medizinische Labordiagnostika AG, is a manufacturer of in vitro diagnostic reagents and automation systems for clinical laboratory testing. The company specializes in immunodiagnostic assays and automated laboratory analyzers serving clinical laboratories, reference laboratories, and hospital laboratories across North America. Core product portfolios include autoimmune disease diagnostics, infectious disease serology (including viral serology for Zika, COVID-19, Oropouche, and other pathogens), allergy testing, endocrinology assays, bone metabolism markers, neurodegeneration biomarkers, and therapeutic drug monitoring. The company manufactures the IDS i20 random access chemiluminescent analyzer, AP2400 automated T-SPOT.TB testing system (FDA-approved), and distributes the ProciseDx platform. EUROIMMUN US offers training and education through its Academy and Pattern IQ learning platform for ANA pattern recognition. The company provides field service and technical support to laboratory customers. Products are designed for CLIA-certified clinical laboratories and diagnostic reference centers. The company is now part of the Revvity organization.

Fujirebio Holdings, Inc. is a subsidiary of H.U. Group Holdings Inc. that specializes in in vitro diagnostics (IVD) biomarker innovation and Contract Development & Manufacturing Organization (CDMO) services. The company drives the biomarker-to-IVD journey through research, clinical validation, and manufacturing partnerships, with a focus on transformative diagnostic solutions across multiple disease areas. Fujirebio's core offering includes the Lumipulse® platform, a fully automated immunoassay system for clinical laboratory testing, alongside manual and semi-automated assay kits (INNO-LIA®, INNO-LiPA®, INNOTEST®, CanAg®). The company manufactures diagnostic instruments, assay kits, software (LIRAS®), quality controls, and raw materials (antibodies and antigens). Primary clinical specialties include neurodegeneration (Alzheimer's disease, multiple sclerosis, Parkinson's disease, ALS), with blood-based biomarkers for amyloid and phosphorylated tau; infectious diseases (HPV genotyping, HPV screening); autoimmune disorders; cardiac markers; tumor markers; fertility and endocrinology; diabetes; and bone metabolism. Recent FDA clearances include blood-based Alzheimer's disease diagnostic tests. The company maintains regulatory credentials including FDA 510(k) clearances and CE marking. Fujirebio operates globally with CDMO partnerships, providing diagnostic raw materials, reagents, and full development and manufacturing services to technology partners and clinical laboratories.

Replacement Parts Industries, Inc. is a leading distributor of original equipment manufacturer (OEM) replacement parts for hospital, medical, dental, and laboratory equipment. Established in 1972 and ISO 9001 certified, RPI supplies critical spare parts and components for sterilization systems (autoclaves, endoscope washers, sterilizers), laboratory equipment (centrifuges, analyzers), patient monitoring devices (blood pressure monitors, ECG/EKG systems), dental equipment (chairs, delivery systems, handpieces), examination furniture, ventilators, and neonatal care systems. The company serves service technicians, biomedical departments, and hospital procurement teams with an extensive searchable catalog of parts organized by equipment type and manufacturer. RPI offers technical assistance, PM guides, troubleshooting support, and maintains rapid fulfillment from its California distribution center.

DIESSE Diagnostica Senese S.p.A. is an Italian manufacturer of in vitro diagnostic (IVD) systems headquartered in Siena, specializing in immunochemistry, infectious disease diagnostics, autoimmune testing, and automated erythrocyte sedimentation rate (ESR) measurement. Founded in the 1980s, the company operates as a research-focused Società Benefit with over 180 employees and exports to more than 100 countries. DIESSE manufactures a comprehensive portfolio of automated and manual diagnostic solutions including the CHORUS EVO platform for immunochemistry, VES-MATIC 5 for ESR analysis with AI integration, AUTO-DAT for standardized seroagglutination testing, Enzywell for manual immunochemistry, and iRapid for rapid immunodiagnostics. All products are produced in-house in Italy, emphasizing quality, sustainability, and ethical practices. The company serves clinical laboratories, hematology centers, and infectious disease diagnostics facilities globally.

Fortis Life Sciences is a strategic platform company based in Waltham, Massachusetts, founded in August 2020. It operates as a multi-subsidiary life sciences tools provider delivering specialized reagents, diagnostic components, and custom development services to biopharma, diagnostics, and research organizations globally. The company integrates five ISO 13485 certified and GMP-compliant North American manufacturing and R&D locations under its "Farm-to-Bench" system, spanning antibody discovery and production, viral vector manufacturing, nanoparticle synthesis, molecular biology reagents, and diagnostic component CDMO services. Core product portfolio includes premium monoclonal and recombinant antibodies (validated for ELISA, Western blot, IHC, flow cytometry, spatial biology), VHH domain libraries (AbNano platform), lateral flow immunoassay components, assay-grade enzymes and master mixes, diagnostic grade nanoparticles (gold, platinum, silica), and lentiviral and AAV vector production. The company also offers contract manufacturing, antibody development, spatial biology imaging services, and precision lyophilization for stable diagnostic products. It serves over 10,000 customers across biopharma, diagnostics OEMs, contract manufacturers, academic research, and applied technology sectors.

Tempus AI is a precision medicine platform that leverages artificial intelligence and multimodal data analytics to accelerate clinical decision-making and drug development. The company provides healthcare providers and researchers with AI-enabled diagnostic and research tools, including genomic sequencing (xT and xR IVD platforms), algorithmic models (such as PurIST for therapy selection), and clinical trial matching capabilities. Tempus integrates extensive molecular profiling with real-world clinical data to identify personalized therapeutic opportunities, support guideline-concordant care, and enable earlier disease diagnosis across oncology and other therapeutic areas. The platform serves academic medical centers, oncologists, pharmaceutical companies, and biotech firms, supporting precision medicine workflows from diagnosis through treatment optimization.

Micro Distributing is a leading supplier of innovative drug and alcohol testing products and services for over 20 years. The company manufactures and distributes the STATTEST brand of testing solutions including urine cups (StatCup), oral fluid tests, hair tests, alcohol analyzers, and reagents. They serve multiple markets: workplace testing (DOT and non-DOT compliant), government and criminal justice systems, educational institutions, behavioral health and addiction treatment facilities, and healthcare providers. The company offers comprehensive solutions including laboratory testing services, collection site networks, compliance management software (STATWARE platform), and DNA paternity testing. Micro Distributing holds FDA clearance, CE marking, CLIA waiver certifications, GMP compliance, and ISO 13485 registration. They are SAMHSA-certified and members of professional associations including DATIA, NDASA, and SAPAA, ensuring adherence to regulatory standards for workplace drug testing and diagnostics.

CMB Lab (Consolidated Medical Bio-Analysis, Inc.) is a full-service CLIA and CAP accredited clinical laboratory established in 1979, providing comprehensive diagnostic services to physicians, hospitals, and pharmaceutical companies. The laboratory offers routine blood analyses, HIV testing, anatomic pathology, and advanced genomic testing. CMB specializes in clinical assays and custom assay development for the pharmaceutical and biotechnology sectors, including biomarker testing and validation across Phase I–IV clinical trials. The company operates multiple patient service centers with courier service and maintains a provider web portal for results management. CMB combines clinical laboratory services with dedicated clinical trials and research capabilities, focusing on early disease detection, diagnosis optimization, and therapeutic monitoring.

Noul Co., Ltd. is a South Korean biotechnology company founded in 2015, specializing in AI-powered in vitro diagnostics and remote diagnosis solutions for infectious and non-infectious diseases. The company's flagship miLab™ platform is an advanced digital diagnostic system that automates blood analysis, sample preparation, and AI-driven pathology interpretation. Noul's product portfolio addresses critical global healthcare challenges, focusing on malaria diagnosis, complete blood count (CBC) and cell morphology analysis, and early cervical cancer detection through AI-powered cytology. The company has established international partnerships and distribution agreements, with presence across multiple countries. Noul's technology delivers significant improvements in diagnostic accessibility, speed (>2x reduction in analysis time), and accuracy, with clinical validation demonstrating high sensitivity and specificity. The company is committed to scaling diagnostic innovation globally, with a vision to impact one billion lives by 2030 through timely, accessible diagnostics for resource-limited and developed healthcare settings.

Thermo Fisher Scientific is a global leader in life sciences and laboratory equipment, consumables, and digital solutions. The company manufactures and distributes a comprehensive portfolio of products for research, diagnostics, and bioprocessing applications across academic, pharmaceutical, biotechnology, and clinical laboratory markets. Product lines include transmission electron microscopes (Glacios 3 Cryo-TEM for structural biology), cell culture media and supplements (Gibco brand), molecular biology reagents (TaqMan and SuperScript PCR systems), transfection reagents (Lipofectamine), assay kits, fetal bovine serum, laboratory consumables (tubes, plates, magnetic beads), and analytical instruments. The company serves drug discovery, genomics, proteomics, cell culture, viral production, and materials analysis workflows. Thermo Fisher operates a robust e-commerce platform with online ordering of thousands of SKUs, technical support resources, interactive media selection tools, and educational content. The organization maintains ISO certifications and FDA compliance for its clinical and diagnostic products, with manufacturing facilities and distribution networks across North America and globally.

CorDx Labs is a biotechnology company specializing in in vitro diagnostic (IVD) products for point-of-care and over-the-counter use. With 18+ years of industry experience, CorDx operates a vertically integrated supply chain with manufacturing facilities across the United States and internationally, serving 170+ countries through a global network of 700+ partners. The company manufactures and distributes a portfolio of 1,000+ diagnostic products spanning infectious disease testing (including multiplex rapid tests for flu, COVID-19, and RSV), reproductive and fertility testing, molecular diagnostics, and pet diagnostics. CorDx also offers contract manufacturing services for diagnostic products across multiple therapeutic areas, leveraging advanced quality and compliance systems to ensure operational excellence.

Onyvia Biolabs (formerly Prove Clinical Laboratories) is a state-of-the-art central laboratory in Sydney's CBD specialising in comprehensive clinical trial services for pharmaceutical companies, biotechs, and CROs. ISO/IEC 17025 accredited by NATA, the laboratory supports Phase I–III trials across multiple therapeutic areas with 6–8 week study startup timelines. Core capabilities include bioanalytical testing via LC-MS/MS and HPLC platforms for pharmacokinetic (PK) analysis, automated ELISA for biomarker testing, safety testing (biochemistry, haematology, coagulation, serology), histopathology with immunohistochemistry and digital imaging, flow cytometry, and PBMC isolation and storage. Additional services encompass kit assembly, sample storage across ambient and ultra-low temperature conditions (-80°C, liquid nitrogen), project management, LIMS database development, international sample logistics, site training, and vendor management. The laboratory is equipped with high-throughput, fully automated analysers and employs a team of PhD-level scientists and clinical pathologists.

Carter BloodCare is a nonprofit community blood center based in Bedford, Texas, and one of the largest blood centers in the United States. Founded in 1951 through a series of mergers, the organization provides over 440,000 blood products annually to more than 200 hospitals and medical facilities across over 50 counties in North, Central, and East Texas. Carter BloodCare offers comprehensive blood services including collection, processing, specialized laboratory testing, storage, and distribution of blood and blood components. The organization conducts over 7,000 mobile blood drives annually, emphasizing community involvement and volunteer donor engagement. With a mission to save lives through transfusion, Carter BloodCare serves diverse patient needs and ensures steady supply of essential blood products to hospitals and healthcare facilities. The center operates with core values of accountability, excellence, and integrity.

Siemens Healthineers AG is a global leader in medical technology specializing in diagnostic imaging, laboratory diagnostics, precision therapy, and advanced healthcare solutions. Founded in 1847 and spun off as an independent entity in 2015, the company employs approximately 74,000 people worldwide and invests over €1 billion annually in research and development. The company's portfolio encompasses advanced imaging technologies including PET-CT scanners, MRI systems, and wireless ultrasound transducers, alongside laboratory diagnostics platforms conducting over 9 billion tests annually. Siemens Healthineers is particularly renowned for precision therapy innovations in oncology, featuring image-guided treatments and radiation therapy solutions. The company operates in more than 70 countries, with solutions trusted by 90% of leading hospitals globally. Its AI-driven diagnostic software and digital tools optimize clinical workflows and support early disease detection, particularly for lung and prostate cancer screening. The company maintains strategic partnerships with major healthcare providers and research institutions to enhance innovation and patient outcomes.

DiaPharma Group, Inc. manufactures specialty research and clinical assay kits, reagents, and hemostasis analyzers for bleeding/clotting disorders, thrombosis, liver disease, drug-induced organ injury, and anti-cancer drug development. Founded in 1997, the company employs scientists with expertise in hemostasis, coagulation testing, platelet function analysis, fibrosis biomarkers, and NETosis research. DiaPharma offers chromogenic substrates, ADAMTS13 assays, Factor X testing, and mechanistic biomarkers for MASH, alcoholic liver disease (ALD), and drug-induced liver injury (DILI). The company provides personalized scientific support and customer service to clinical laboratories, research institutions, and pharmaceutical development teams.

SST International Inc. (Scientific Supplies & Technology Int'l) is a Miami-based medical and laboratory equipment distributor serving healthcare facilities, clinical laboratories, research institutions, and water testing facilities across the Caribbean, Central, and South America since 1977. The company provides access to thousands of diagnostic and laboratory products from over 150 trusted manufacturers, including hematology analyzers, immunoassay systems, PCR equipment, microbiology analyzers, and comprehensive laboratory consumables (pipettes, specimen containers, reagents, blood collection tubes). SST offers factory-trained field service engineers located across the Americas for rapid equipment service and support, specializing in point-of-care testing systems, laboratory automation solutions, and chemistry analyzers. The company serves hospitals, clinics, private and public clinical laboratories, industry quality control labs, water testing laboratories, and research institutions with reagents, consumables, chemicals, furnishings, and equipment.

Hemagen Diagnostics is a biotechnology company specializing in clinical diagnostic solutions for over 20 years. The company manufactures FDA-approved diagnostic kits and testing supplies for both human and veterinary applications. Hemagen offers a comprehensive portfolio including gold-standard immunofluorescence assay (IFA) products for autoimmune and infectious disease testing, as well as ELISA, hemagglutination (HA), and point-of-care (POC) testing solutions. The company serves clinical laboratories, veterinary practices, and blood banks with diagnostic assays designed for ease of use and clinical accuracy.

Abcam is a leading life sciences company providing over 110,000 biological research products and reagents to approximately 750,000 researchers across 130+ countries. The company specializes in primary and secondary antibodies, recombinant antibodies (37,000+ offerings, including 4,900 knockout-validated variants), immunoassays, ELISA kits, proteins, peptides, gene-edited cell lines, and cellular activity assays. Abcam's product portfolio supports critical research in cancer, neurological disorders, infectious diseases, and metabolic disorders. The company is known for data-rich technical specifications, validation data, and high-citation rates among peer researchers. Abcam pioneered e-commerce and data-sharing platforms in life sciences, streamlining antibody and reagent sourcing for academic and pharmaceutical research. Recent innovations include SimpleStep Ignite™ ELISA kits offering 50x greater sensitivity, MollAI AI-powered product recommendation tools, and trial-size antibody offerings to reduce research costs and validation risk.

Nova Biomedical is a privately held, globally-leading in vitro diagnostic (IVD) company founded in 1976 and headquartered in Waltham, Massachusetts. The largest privately owned diagnostic company in the United States, Nova Biomedical employs over 1,500 people across manufacturing facilities in Massachusetts and Taipei, Taiwan, serving 110+ countries through its global distributor network. The company specializes in advanced blood testing and analytical instrumentation, with a comprehensive portfolio including critical care blood gas analyzers (StatProfile® Prime series), point-of-care glucose meters (StatStrip®, NovaMax®), cell culture analyzers (BioProfile® Flex), clinical and bioprocessing osmometers, liquid volume verification systems, and automated CSF cell counters. Nova Biomedical serves hospitals, emergency departments, blood banks, biotech/pharmaceutical manufacturers, clinical research laboratories, and veterinary diagnostics markets. The company operates through multiple trusted brand portfolios including Advanced Instruments, BioProfile, StatProfile, StatStrip, Artel, Solentim, and GloCyte, delivering solutions for bioprocessing, clinical diagnostics, and veterinary applications with emphasis on improving patient outcomes and operational efficiency.

umedwings is a B2B medical device distributor and supply aggregator that facilitates direct ordering from multiple medical device manufacturers. The platform curates and distributes a broad range of medical equipment including diagnostic instruments (PCR kits, blood gas and electrolyte analyzers), patient monitoring systems (multiparameter monitors, ECG machines), intensive care equipment (ICU ventilators, infusion pumps, defibrillators), ultrasound diagnostic systems, anesthesia machines, oxygen delivery systems, and hospital furniture. The company serves healthcare facilities and veterinary clinics, offering products from numerous OEM partners including Bioperfectus, Cornley, Dartmon, Biolight, Northern Medical, EMP, and Wisonic. This B2B marketplace model enables hospitals and clinics to access manufacturing-direct pricing on essential medical equipment without intermediary markups.

ZeptoMetrix is a leading biotechnology company specializing in quality controls, assay development services, analytical reference materials, and proficiency testing for infectious disease diagnostics and analytical markets. Founded in 1999 and headquartered in Buffalo, New York, the company operates as a division of Antylia Scientific. ZeptoMetrix serves diagnostic microbiology, oncology, environmental testing, food & agriculture, cannabis & hemp, and pharmaceutical sectors. The company offers molecular controls for diagnostic testing, analytical reference materials including certified reference materials (CRMs) for environmental contaminants (PFAS, microplastics, pesticides, organotins), food safety standards, cannabis potency testing compounds, and pharmaceutical reference standards. ZeptoMetrix provides ISO 17043-accredited proficiency testing programs, viral lysates and culture fluids, seroconversion panels, monoclonal and polyclonal antibodies, ELISA kits, microbiological controls, and oncology molecular controls. With approximately 106-200 employees and ~$10M annual revenue, ZeptoMetrix serves global customers through direct sales and distributor networks, supported by comprehensive technical documentation and regulatory compliance resources.

Vidan Diagnostics is a B2B medical diagnostic supplier headquartered in San Antonio, Texas, specializing in laboratory diagnostic reagents and assays for critical clinical areas. The company distributes high-quality, FDA-cleared diagnostic products focused on diabetes management, sepsis biomarker detection, cardiovascular disease assessment, and anemia diagnosis. As the exclusive U.S. distributor for DiaSys Diagnostic Systems' Procalcitonin FS Assay, Vidan serves hospital laboratories and clinical diagnostic facilities with proven, easy-to-use technology platforms. The company's product portfolio emphasizes biomarker-based testing to improve patient outcomes and reduce hospital mortality, particularly in sepsis and chronic disease management.

ABOUND Diagnostics, Inc. is a San Diego-based in vitro diagnostic (IVD) manufacturer specializing in rapid diagnostic tests and point-of-care testing (POCT) products for both human and veterinary health markets. The company offers a comprehensive portfolio including rapid tests for women's health, drugs of abuse, infectious diseases, tumor markers, and cardiac markers; blood glucose monitoring systems (VivaGuard® Ino, VQ PET H); lancing devices and lancets; infrared thermometers; urinalysis and biochemistry reagent strips; and fluorescence immunoassay (FIA) and chemiluminescence immunoassay (CLIA) test kits. ABOUND serves US and international markets, with a mission to deliver high-quality, affordable diagnostic solutions that improve healthcare access globally.

NuWav Labs is a CLIA-certified, COLA-accredited clinical laboratory offering comprehensive diagnostic solutions including core laboratory testing (chemistry, hematology, immunology), molecular diagnostics (COVID-19, Flu A/B, RSV), and high-quality reagents and kits for healthcare providers and diagnostic laboratories. The company specializes in fast turnaround times with 99% accuracy across 500+ test types, operating under HIPAA compliance and federal regulatory standards. NuWav serves as a scalable diagnostic partner for hospitals, clinics, and research institutions requiring reliable laboratory testing and reagent supply.

Enable Biosciences is a South San Francisco-based diagnostics company spun out of UC Berkeley and Stanford in 2016. The company develops ultrasensitive immunoassays for early detection and risk stratification of autoimmune and infectious diseases, with particular expertise in Type 1 Diabetes autoantibody screening and detection. Their ADAP (Advanced Diagnostics for Autoimmune Prediction) technology platform enables predictive medicine through proprietary whole blood autoantibody detection methods. The company partners with leading institutions including Stanford Healthcare, Harvard Medical School, California Department of Public Health, and JDRF, and has performed over 150,000 tests to date. Enable Biosciences' assays support early intervention and clinical decision-making for diabetes risk prediction and population-based screening programs.

Fertility Solutions is a specialized manufacturer and CLIA high-complexity laboratory provider focused exclusively on semen analysis solutions. Based in Warrensville Heights, Ohio, and serving the Cleveland region for over 30 years, the company manufactures FDA-cleared semen analysis quality controls and laboratory reagents. Their product portfolio includes quality control materials for sperm count, morphology, motility, viability, and post-vasectomy assessment, as well as specialized staining kits and diagnostic instruments like the Spermocytometer. Beyond manufacturing, Fertility Solutions operates a certified laboratory providing semen analysis services for patients and contract research, and offers comprehensive competency training programs, post-training examinations, and validation sets to support clinical laboratory compliance with CLIA requirements. The company also serves veterinary applications for bovine, porcine, equine, and avian fertility assessment.

Perosphere Technologies is a private medical technology company specializing in coagulation diagnostics and point-of-care testing solutions. The company develops and manufactures the Perosphere ClotChek, a CE-marked pharmacodynamic, reagent-free coagulation assay that provides a global view of coagulation status at the patient bedside. The handheld, battery-powered device delivers lab-precision results within 3-8 minutes with remarkably low variability, enabling rapid clinical decision-making in coagulation management. Perosphere's product portfolio also includes the WBCT Assay (whole blood clotting time assay) with room-temperature storage capability and liquid quality controls for normal and anticoagulated samples. With 16 patents in blood testing and coagulation systems, the company focuses on making diagnosis, treatment, and prevention in coagulation management immediately accessible through actionable data. Positioned as a B2B medical device manufacturer, Perosphere serves clinical laboratories, point-of-care testing environments, and bedside diagnostic needs.

InBios International, Inc. is a privately-held biotechnology company specializing in the design, development, and manufacture of immunodiagnostic devices for infectious diseases and biothreats. Founded in 1996 and headquartered in Seattle, Washington, the company operates a state-of-the-art GMP-compliant, FDA-registered manufacturing facility certified to ISO 13485:2016. InBios maintains a portfolio of over 25 FDA-cleared diagnostic products and extensive life science reagent catalogs. Core offerings include ELISA kits, rapid point-of-care tests, and contract manufacturing services for emerging infectious disease diagnostics. The company delivers immunoassays targeting dengue, West Nile virus, Zika, Chagas disease, leishmaniasis, COVID-19, influenza, and biothreats such as anthrax and melioidosis. InBios provides comprehensive assay development, regulatory affairs support, and contract manufacturing capabilities to clinical laboratories, public health agencies, research institutions, and OEM partners globally. The company is recognized for rapid response to emerging disease threats while maintaining rigorous quality standards and cost-effective solutions for the global diagnostic market.

HealthChek Network, LLC is a family-owned wellness screening provider founded in 1985, operating affordable health and laboratory testing services across Indiana, Illinois, Wisconsin, and Michigan. The company specializes in accessible wellness screenings, drug testing, seasonal vaccinations, and clinical laboratory testing with a commitment to eliminating patient anxiety around blood draws. HealthChek operates physical screening locations in Schererville, IN and Streator, IL, and offers on-site screening events at client locations. Their services emphasize early detection and prevention, with reasonable pricing, professional technicians, and customer privacy as core values. The company accepts multiple payment options and provides fast, reliable results sent directly to patients and healthcare providers.

ARUP Laboratories is a national, academic, nonprofit reference laboratory established in 1984 as part of the University of Utah's Department of Pathology. Operating 65 highly automated laboratory facilities with 4,300 employees, ARUP serves healthcare providers nationwide with over 3,000 diagnostic tests. The laboratory maintains a two-story freezer capable of storing 2.3 million specimens and provides industry-leading turnaround times. ARUP's test menu encompasses genetics, molecular oncology, pediatrics, neurology, hematopathology, and infectious disease testing. Beyond core laboratory services, ARUP offers comprehensive consulting through its Healthcare Advisory Services division, addressing laboratory stewardship, operations optimization, outreach planning, and data analytics. The company maintains a robust research and innovation program through its Institute for Research and Innovation in Diagnostic and Precision Medicine, supporting clinical trials, pharmaceutical companion diagnostics, and academic research initiatives. ARUP provides ARUP Consult®, a clinical decision support resource featuring testing algorithms and expert insights, alongside continuing education for laboratory professionals. CAP-, CLIA-, and ISO 15189-accredited, ARUP serves academic medical centers, children's hospitals, government facilities, and healthcare systems across the U.S.

CEIBA Health Technologies is an AI-powered healthcare technology platform specializing in virtual clinical care and medical device connectivity solutions. The company delivers an integrated Enterprise Suite with four core capabilities: (1) IoMT Interoperability—featuring a plug-and-play IoMT Box with 1,000+ pre-installed device drivers supporting 20+ EHR integrations; (2) Continuous Monitoring—delivering real-time telemetry dashboards for patient monitors, ventilators, infusion pumps, blood gas analyzers, and EEG machines across ICU, med-surge, LTACH, and SNF settings; (3) Decision Support & Workflow—providing actionable clinical insights and operational dashboards; and (4) Virtual Clinical Care—a telehealth platform enabling multi-specialty consultations, remote rounding, and acute care at home. CEIBA's protocol-agnostic architecture supports HL7, FHIR, JSON, and XML with enterprise-grade security, encrypted data transfer, and full mobile functionality. The platform is designed for rapid deployment (days vs. months) and serves hospitals and health systems in the US and internationally.

Cytovale is a medical diagnostics company headquartered in South San Francisco, specializing in rapid sepsis detection and immune-mediated disease diagnostics. The company's flagship product, IntelliSep®, is an FDA-cleared in vitro diagnostic test that delivers sepsis risk stratification results in approximately 8 minutes from a standard blood draw. IntelliSep analyzes the biomechanical properties of white blood cells to assess immune activation and predict the probability of sepsis with organ dysfunction within 3 days of testing. Designed for emergency departments, IntelliSep enables rapid patient triage, reduces unnecessary antibiotic use and blood cultures, shortens length of stay, and improves operational throughput. The company's deformability cytometry platform represents a significant advancement in rapid infectious disease diagnostics, addressing a critical gap in sepsis detection where earlier treatment initiation directly correlates with improved patient survival outcomes.

MP Biomedicals is a global life science company founded in 1959 and headquartered in Irvine, California. The company develops, manufactures, and distributes over 55,000 products, including life science reagents, fine chemicals, in vitro diagnostics, and dosimetry tools. It serves a wide range of researchers, from those in basic research to full-scale production. As a wholly-owned subsidiary of Valiant Co., Ltd., MP Biomedicals operates ISO-certified and FDA-approved facilities worldwide. The company employs between 533 and 827 people and has reported annual revenues ranging from $87.5 million to $279.2 million. Its product portfolio includes reagents for research, large-scale fine chemicals, diagnostic tools like monoclonal antibodies and ELISA kits, specialized dosimetry products, sample preparation systems, nucleic acid extraction kits, cell culture media, mycoplasma control solutions, and laboratory automation instruments. MP Biomedicals is committed to supporting scientific discovery in biotechnology and diagnostics, catering to the needs of scientists and organizations in these fields.

KBMO Diagnostics is a clinical laboratory specializing in advanced diagnostic testing for food sensitivities and gut health. The company offers the FIT (Food Inflammation Test), a patented, multi-pathway delayed food sensitivity test that measures both IgG antibodies and immune complexes—the primary food-related immune pathways. KBMO's tests are designed for healthcare providers to identify food reactivities that contribute to inflammation, autoimmune conditions, and chronic diseases including skin rashes, intestinal disorders, brain fog, and arthritis. The company provides fingerstick bloodspot collection kits for at-home testing, comprehensive personalized reports, and practitioner tools including rotation diet recommendations and integration with supplement dispensing platforms (Fullscript). KBMO also offers complementary protocols (NutriDyn, Microbiome, Biotics) to support clinical outcomes. Services target functional medicine practitioners, naturopaths, nutritionists, and chiropractors seeking actionable patient data for personalized therapeutic interventions.

BloodScan Biotech Inc. is a biotechnology company specializing in liquid biopsy technology, founded in 2023 by a research team from the University of Michigan. The company develops and commercializes the Labyrinth One—an automated circulating tumor cell (CTC) enrichment system that isolates intact cancer cells directly from blood samples. This microfluidic-based platform enables non-invasive cancer diagnosis, monitoring, and personalized treatment selection across solid tumors from stage 0 to stage 4. The technology achieves near-100% sensitivity in advanced cancers, detects pre-invasive lesions, and delivers 97% genomic concordance with tissue biopsies. BloodScan's innovation addresses critical gaps where traditional tissue biopsy is unsafe, impractical, or impossible, providing clinicians and researchers with biopsy-equivalent insights from a simple blood draw. The company serves clinical diagnostic, research, and precision oncology applications.

Proteintech Group is a biotechnology company specializing in high-quality antibodies and protein research reagents for life sciences and pharmaceutical research. Founded in 2001 by scientists and headquartered in Rosemont, Illinois, the company manufactures a comprehensive catalog of antibodies, immunoassays, recombinant proteins, and nanobody-based reagents. Proteintech offers antibodies against 12,000+ human targets, 100+ sandwich ELISA kits, 4,000+ recombinant fusion proteins, and cGMP-grade cytokines and growth factors. Products include primary and secondary antibodies (monoclonal, polyclonal, and recombinant), conjugated antibodies for immunofluorescence and flow cytometry, immunohistochemistry kits, and magnetic cell separation kits. The company emphasizes in-house manufacturing, reproducibility, and a "scientists for scientists" approach, with products cited in over 20,000 peer-reviewed publications. Custom antibody services, polyclonal antibody production, and GMP-grade proteins support drug development and cell/gene therapy applications. Recently launched Able AI—a product recommendation tool—to accelerate scientific discovery.

Sinocare Inc. is a leading global biosensing technology company specializing in rapid diagnostic test products for chronic disease management, particularly diabetes. Founded in 2002 and headquartered in Changsha, Hunan Province, China, the company ranks #1 in blood glucose meter (BGM) markets in China and #4 worldwide, serving over 25 million users across 187 countries and regions. Sinocare went public in 2011 with 2022 revenues of approximately $248 million. The company develops and manufactures a comprehensive product portfolio including blood glucose meters, test strips, continuous glucose monitoring (CGM) systems, blood pressure monitors, and multiparameter diagnostic devices. Additionally, Sinocare provides hospital diabetes management systems and integrated digital health solutions combining biosensing technology with smart healthcare platforms. With 9 global R&D and manufacturing sites, the company has established substantial international presence through strategic acquisitions including Nipro Diagnostic Inc. and PTS Diagnostics Inc., positioning itself as a comprehensive chronic disease management solution provider for both individual patients and healthcare institutions.

Savyon Diagnostics is an Israeli in vitro diagnostics company founded in 1984, specializing in developing, manufacturing, and marketing high-quality diagnostic test systems. The company focuses on infectious disease diagnosis and genetic screening with over 100 different test markers. Savyon employs multiple diagnostic techniques including ELISA, Microimmunofluorescence, Immunoprecipitation Assay, immunochromatographic rapid kits, and DNA/RNA Micro Arrays. The NanoCHIP platform is a key innovation—an automated instrument for high-throughput multi-analyte molecular testing used in clinical microbiology, genetics, and pathology laboratories. Beyond clinical diagnostics, Savyon offers contract development and manufacturing services for biotech companies, genetic and molecular lab services, and GMP-certified analytical services for pharmaceutical companies and research institutes. The company serves clinical laboratories, point-of-care settings, and home-use diagnostic markets, with recent expansion into consumer-facing products such as Savvycheck, a self-testing kit for vaginal yeast infection diagnosis.

EQM Research, Inc. is a designer, manufacturer, and distributor of the Test-mate ChE Cholinesterase Test System. This specialized diagnostic platform measures acetylcholinesterase (AChE) and pseudocholinesterase (PChE) activity in clinical samples. The system is used for assessing cholinesterase levels, with applications in toxicology screening, pesticide exposure monitoring, and baseline health assessments. EQM Research provides comprehensive documentation including instruction manuals, package inserts for assay kits, clinical trial data, and technical support policies. The Test-mate ChE represents a focused laboratory diagnostic solution for cholinesterase measurement in clinical and research settings.

Lab Warehouse, Inc. is a clinical laboratory supplier and distributor headquartered in Puerto Rico, established in 1993. The company specializes in hematology, chemistry, urinalysis, and coagulation instruments; rapid diagnostic tests for infectious diseases, pregnancy, and drug screening; laboratory reagents and consumables; and specimen handling equipment including microscopes, centrifuges, and mixers. Lab Warehouse also develops and markets BestLab.net, a comprehensive laboratory information and management system (LIMS) designed for full clinical laboratory automation with compliance to CLIA, HIPAA, and local regulations. The system provides patient data management, quality control programs, electronic billing, workflow analysis, and decision-support analytics for laboratory administrators. The company serves clinical laboratories, physician offices, and veterinary laboratories across Puerto Rico, with expansion into the U.S., Central America, South America, and the Caribbean.

Solomon Park Research Laboratories has supplied high-quality human serum, plasma, and biospecimens to clinical and research laboratories globally since 1984. Operating from their Burien, Washington facility, they specialize in commutable quality blood products collected via the CDC-developed CLSI C37-A procedure. Their offerings include AccuBase-CQM™ frozen serum and plasma with known analyte levels (lipids, chemistry markers), fresh whole blood and urine pools, and SPRL-RefKits™ analyte reference control kits for CAP proficiency testing and equipment calibration. Solomon Park also provides cryogenic ultra-low temperature storage (SPRL-StoTrac™) with 24/7 redundant power protection for longitudinal studies and global logistics. They support over 2,000 customers across 10 countries, offering custom donor acquisition, characterization, and proficiency testing materials for equipment manufacturers, metrology experts, and diagnostic equipment validation.

Numares Health is a precision diagnostics company specializing in AI-enabled biomarker tests using nuclear magnetic resonance (NMR) spectroscopy and machine learning. Founded as a spin-off from Regensburg University, the company develops in vitro diagnostic (IVD) tests for metabolic dysfunction-related diseases, including chronic kidney, liver, and cardiac conditions. The flagship AXINON® System is an FDA-cleared platform that quantifies multiple biomarkers from a single serum sample using multiplex metabolomics. Current product portfolio includes AXINON® LDL-p Test System (cardiovascular risk assessment, FDA-cleared in US and CE-marked in EU), AXINON® GFR(NMR) (kidney function assessment using novel biomarkers valine and myo-inositol alongside creatinine and cystatin C, CE-marked), AXINON® lipoFIT® (cardiovascular risk assessment, CE-marked), and AXINON® HCC(NMR) (liver cancer detection, in development). The company operates from Houston, Texas and Regensburg, Germany, collaborating with institutions such as Mayo Clinic and Oxford University to advance clinical integration of metabolomics-based diagnostics.

Novascope Biochips Inc. is a diagnostic platform developer pioneering next-generation point-of-care and laboratory diagnostics using proprietary BioChips Reaction (BCR) technology. The platform delivers ultra-high sensitivity detection of DNA, proteins, and small molecules with quick turnaround times, multiplexing capability, and minimal sample volumes. Applications span lab medicine, primary care, and point-of-care testing (POCT). The company emphasizes secure data transfer to mobile devices, making results accessible in clinical and home-care settings. Core strengths include affordability, rapid analysis, and comprehensive healthcare application coverage from centralized laboratory to decentralized primary care environments.

Gold Standard Diagnostics (GSD) is a global diagnostic solutions provider headquartered in Dietzenbach, Germany, specializing in the development, manufacturing, and commercialization of diagnostic test kits, reagents, instruments, and automation systems. Formed through strategic mergers including Virotech Diagnostics and Novatec Immunodiagnostica, GSD serves clinical, food, feed, environmental, biopharma, veterinary, and animal health sectors. The company offers comprehensive diagnostic workflows including ELISA test kits, PCR assays, lateral flow devices, and automated platforms for virology, bacteriology, oncology, allergen detection, food pathogen identification, and mycotoxin analysis. GSD provides magnetic separation solutions, culture media, sampling devices, and reference materials. All products emphasize quality and compliance with CE-IVD marking under EU regulations. Services include antibody development, technical support, and training for laboratories, healthcare professionals, and research institutions.

Haemonetics Corporation is a global medical technology company headquartered in Boston, Massachusetts, specializing in blood management, plasma collection, and vascular closure solutions for hospitals, blood centers, and plasma donation centers. The company develops innovative devices and software platforms that improve patient care quality, clinical outcomes, and operational efficiency across transfusion medicine and interventional procedures. Product portfolio includes blood collection and processing systems, plasma collection platforms, blood testing and safety solutions, and vascular closure devices. The company serves three primary market segments: hospitals (advancing surgical and critical care outcomes), blood centers (optimizing collection efficiency and blood component availability), and plasma centers (enhancing donor experience and collection yield). Haemonetics maintains FDA clearances and approvals for its portfolio, as evidenced by recent FDA approvals including expanded labeling for the VASCADE MVP® XL Venous Vascular Closure System and FDA clearance for the NexSys® PCS Plasma Collection System with Persona® PLUS Technology. The company is publicly traded and demonstrates commitment to regulatory compliance, operational excellence, and continuous innovation in transfusion medicine and interventional vascular technologies. Manufacturing and service capabilities span device production, software platforms, and customer support infrastructure.

VivaChek Diagnostics, Inc. is a Sacramento, CA-based subsidiary of VivaChek Biotech, a global point-of-care testing (POCT) manufacturer established in 2013. The company specializes in blood glucose monitoring systems, drugs-of-abuse testing solutions, and related diagnostic devices. VivaChek operates globally across 120+ countries, offering OEM, ODM, and manufacturing services. Product lines include FDA-cleared blood glucose meters (including the VivaChek Link Plus 4G system with advanced FAD enzyme technology), multi-drug urine test cups, fentanyl-specific FIA test kits, and the BioSieve Toxismart FIA Reader platform. Recent FDA clearances include: three glucose meters (2024), BioSieve Fentanyl FIA Home Test Kit and Reader for OTC use (2024), VivaChek Link Plus 4G (2023), and Multi-Drug Urine Test Cup (2023). The company also manufactures lactate analyzers and multifunction monitoring systems. VivaChek maintains FDA 510(k) clearances and demonstrates commitment to quality and innovation through participation in major medical trade shows (Medica, FIME). The company serves workplace drug testing, clinical diagnostics, and home health monitoring markets.

Sejoy is a high-tech medical device manufacturer founded in 2002, specializing in home-care electronic medical products and point-of-care diagnostic systems. The company designs, develops, manufactures, and markets a comprehensive portfolio of monitoring and testing devices including blood glucose monitoring systems, lipid panel analyzers, hemoglobin monitoring systems, uric acid monitoring systems, urine analysis systems, infectious disease testing platforms, drug-of-abuse testing solutions, and fertility testing systems. All products are manufactured under ISO 13485 quality management standards and hold regulatory certifications including FDA approval, CE marking (European), RoHS, REACH, MDSAP, and FCC compliance. Sejoy operates three major technology research and development platforms: electromechanical, optoelectronic, and biochemical. The company maintains a strong R&D team with over 80% of staff holding bachelor's or master's degrees. Manufacturing capabilities include full quality control protocols (IQC, IPQC, FQC, OQC) with 100% pre-shipment inspection. The company offers OEM/ODM services for customization of color, packaging, user manuals, and functional design modifications. Warranty coverage includes one year of complimentary service with lifetime after-sales support. Sejoy serves global markets with a focus on cost-effective, clinically validated diagnostic instruments suitable for clinical laboratories, point-of-care facilities, and home health monitoring applications.

J.P. Gilbert Co. manufactures and services the Hemaprep® and Miniprep® automated blood smearing instruments. These devices are designed for clinical laboratory applications, automating the preparation of blood smears for microscopic analysis. The company provides both equipment sales and comprehensive parts/service support to healthcare facilities and laboratory settings.

PixCell Medical manufactures HemoScreen, a portable point-of-care (POC) complete blood count (CBC) analyzer designed to perform complex hematological testing in non-laboratory settings. The device delivers results in approximately 5 minutes and includes a 5-part differential count with clinical accuracy comparable to centralized laboratory instruments. The technology employs microfluidics, Lab-On-A-Cartridge design, and viscoelastic focusing—a proprietary physical phenomenon that aligns blood cells into a monolayer for optical analysis. HemoScreen accepts both venous and capillary (finger-stick) samples, enabling deployment in emergency departments, urgent care clinics, oncology practices, mental health facilities, primary care centers, and homecare settings. The company markets to healthcare practitioners and institutions seeking rapid turnaround for critical hematological decision-making. Testimonials from NHS trusts, university medical centers, and international healthcare systems indicate clinical adoption in the UK, Sweden, Denmark, and US. The device has received FDA clearance and is recognized by clinical organizations including AACC for disruptive technology. Manufacturing and service capabilities support both institutional and point-of-care deployment models.

Tecan Group AG is a global life sciences and diagnostics company specializing in laboratory automation, microplate readers, microplate washers, liquid handling systems, and molecular diagnostics solutions. The company serves research institutions, clinical laboratories, and diagnostic centers with a comprehensive portfolio of hardware platforms, reagents, software, and custom automation solutions. Key product lines include the Fluent® and Veya® laboratory automation workstations, Freedom EVO® platform, microplate readers (Spark®, Infinite® series, Sunrise™), and microplate washers (HydroFlex™, HydroSpeed™). The diagnostics division provides mass spectrometry sample preparation systems, positive pressure workstations (Resolvex), and pre/post-analytical automation solutions. Tecan also manufactures next-generation sequencing (NGS) library prep reagents and consumables under brands including Celero, Revelo, and Ultralow DNA-Seq kits. The company's software offerings (FluentControl™, Freedom EVOware®, Magellan™, i-control™, Introspect™) support workflow automation and data management across genomics, proteomics, immunoassay, and clinical diagnostics applications. Manufacturing and OEM partnering services through the Partnering division include liquid handling components, robotic technologies (Cavro systems), and contract manufacturing capabilities. Tecan maintains ISO 13485 quality certification and operates globally with headquarters in Switzerland and significant operations in the US, Europe, and Asia-Pacific. Products are marketed to pharmaceutical research, biotech, clinical laboratories, and diagnostic service providers.

Helena Laboratories is a leading American manufacturer of clinical laboratory instruments and reagents with over 60 years of experience. The company specializes in gel and capillary electrophoresis systems for protein, immunofixation, hemoglobin, and cholesterol testing. Their product portfolio includes the SPIFE Nexus and V8 Nexus CE systems for automated gel and capillary electrophoresis with integrated reporting capabilities, the Touch Series (SPIFE Touch, ESH Touch, QS Touch Plus) for integrated gel electrophoresis with advanced data management and LIS interfaces, and point-of-care hemostasis instruments including Plateletworks for functional platelet analysis and Actalyke ACT analyzers for hemostatic monitoring. Helena also manufactures fecal occult blood (FOBT) test kits, hemostasis reagents, immunology and protein diagnostic systems, and disposable laboratory plasticware. The company maintains corporate headquarters and manufacturing facilities in Beaumont, Texas, comprising over 250,000 square feet of research, manufacturing, inventory, engineering, and administrative space. Helena holds over 40 registered patents and has been awarded the U.S. Secretary of Commerce "E" Award for export excellence. The company serves major medical centers, reference laboratories, hospitals, and private practices worldwide through three international subsidiaries and over 65 international distributors, supported by 24-hour technical hotline service and approximately 75 field specialists throughout the United States.

SEKISUI Diagnostics is a global leader in diagnostic reagents, biochemistry products, and point-of-care testing solutions with over 40 years of industry experience. The company manufactures and supplies clinical chemistry reagents, performing over 1.8 billion tests annually worldwide. Core product lines include Clinical Chemistry reagents for laboratory analyzers, Point-of-Care Testing (POCT) solutions in multiple formats to enable rapid diagnosis in office and clinic settings, and specialty biochemical enzymes for diagnostic reagent and biosensor manufacturers. SEKISUI also provides Blood Collection Tube Raw Materials and pre-analytic systems for plasma collection tubes, serving blood collection manufacturers globally. The Metrix® COVID/Flu Test represents their molecular diagnostics portfolio, offering point-of-care detection and differentiation of SARS-CoV-2, Flu A, and Flu B with small footprint and streamlined workflow. Beyond products, SEKISUI offers Biopharma Services supporting biotherapeutic and pharmaceutical manufacturing, technical transfer, and process scale-up. The company serves core laboratories, healthcare providers, in vitro diagnostics manufacturers, and distributors. SEKISUI combines analytical accuracy with operational efficiency, positioning products for cost containment and outcome improvement across clinical settings. The organization emphasizes patient-centric diagnostic solutions and maintains comprehensive technical and educational support for laboratory and clinical professionals.

Inanovate Inc. is a clinical laboratory diagnostics company headquartered in Sioux Falls, South Dakota, with additional operations in Raleigh, North Carolina. The company develops and commercializes the Bio-ID, a proprietary bench-top protein screening analyzer platform designed to detect and measure multiple disease-related biological molecules (biomarkers) from patient blood samples. The Bio-ID platform integrates Inanovate's proprietary Longitudinal Assay Screening (LAS) technology, developed since 2010, which enables accurate detection and measurement of complex protein signatures at virtually any concentration without requiring multiple sample dilutions or complex sample preparation. The Bio-ID consists of a compact analyzer and disposable test cartridges; end users load samples into cartridges, insert them into the analyzer, and the system automatically performs analysis. The technology is positioned to reduce diagnostic testing costs while improving accuracy and serves both research and clinical markets. Inanovate's mission focuses on enabling access to the diagnostic power of the proteome through multiplexed serological analysis. The company offers the Bio-ID 800 analyzer, disposable test cartridges, an alliance program for research partners, and associated services. Products enable next-generation diagnostic and therapeutic development across various disease applications. The company has completed technology validation and benchmarking of its core platform.

RR Mechatronics Manufacturing B.V. is a specialized manufacturer of hematology in vitro diagnostic (IVD) instruments with over 35 years of experience in development, manufacturing, sales, and service. The company operates globally across 40+ countries with a US subsidiary (Mechatronics USA, LLC) based in Warwick, Rhode Island. RR Mechatronics develops and produces three primary product lines: Starrsed (automated erythrocyte sedimentation rate [ESR] instruments), Lorrca (red blood cell functional analysis systems), and Corrmi (reagent preparation and reconstitution instruments). Starrsed instruments follow the Westergren gold standard for ESR measurement and range from small-capacity to high-capacity, highly automated laboratory systems. Lorrca is a Research Use Only (RUO) instrument that performs quantitative functional measurements of red blood cell deformability to identify hereditary and acquired membrane disorders and anemias. Corrmi provides environmental and logistical savings through concentrated reagent reconstitution. The company maintains strict quality management and regulatory compliance procedures. RR Mechatronics operates a global distribution network with certified partners providing training, maintenance, and emergency service support. The company also operates an Academy program supporting universities, clinical researchers, and patient organizations in diagnostic development collaboration.

Sartorius is a global life sciences company founded in 1870, specializing in bioprocess solutions, laboratory instrumentation, and technologies for biopharmaceutical research and manufacturing. The company provides an integrated portfolio spanning from lab-scale research to large-scale medication manufacturing, including single-use bioprocess systems, bioreactors and fermenters, process filtration and chromatography, cell culture media, weighing and pipetting instruments, process analytical technology (PAT), live-cell imaging systems, and water purification solutions. Sartorius serves pharmaceutical companies, researchers, and biotech manufacturers with mission-critical tools for drug development, cell therapy manufacturing, and bioprocess optimization. The company operates globally with ~14,000 employees and generates approximately €3.5 billion in annual revenue, committed to advancing biopharmaceutical innovation and sustainable manufacturing practices.